COMPREHENSIVE PAN-CANCER ANALYSIS AND EXPERIMENTS REVEALED R3HDM1 AS A NOVEL PREDICTIVE BIOMARKER FOR PROGNOSIS AND IMMUNE THERAPY RESPONSE



Account has been disabled due to a violation of Terms of Service.

Contact Moderators